February 10, 2009 - Sorin Group said today it acquired the Clearglide endoscopic vessel harvesting (EVH) product line of Datascope Inc., which enables less-invasive harvesting of vessels for use in coronary artery bypass grafting.

February 10, 2009 - W. L. Gore and Associates today said at the annual International Congress of Endovascular Interventions XXII, it received FDA approval to market a modified version of the GORE TAG Thoracic Endoprosthesis for the treatment of thoracic aortic aneurysms (TAAs).

February 10, 2009 - Hospitals will be eligible in Medicare’s 2009 fiscal year for up to an additional $53,000 in reimbursement when they implant a CardioWest temporary Total Artificial Heart (TAH-t) compared to subsequently transplanting a donor heart.

Codonics Horizon is three imagers in one – a dry film imager, color imager, and grayscale paper imager. Switching between film, color and paper requires no operator intervention. The all-in-one imager aims to provide high quality images while being affordable.

Integrity Disk Importer is designed to be an easy-to-use solution to read, reconcile and store medical studies from a disc into PACS, or allows DICOM images to be stored directly to Integrity from any network device.


February 9, 2009 - Biosense Webster Inc. said Friday the FDA granted market clearance for the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.

February 9, 2009 - Implantation of drug-eluting stents to treat degenerative in aortocoronary saphenous vein graft (SVG) lesions is safe, according to a study published in the Jan. 15 issue of the American Journal of Cardiology (Vol. 103, issue 2, Pages 199-202).

February 9, 2009 – Some patients who suffer a stroke as a result of a blockage in an artery in the brain may benefit from a clot-busting drug nine or more hours after the onset of symptoms, according to findings published in the online edition of Radiology.

February 9, 2009 - Emory University cardiologists are testing a modification of angioplasty known as postconditioning, designed to reduce permanent damage to the heart muscle after a heart attack.

February 6, 2009 - Biosense Webster Inc., a Johnson & Johnson company, today said the FDA granted market approval to the NaviStar ThermoCool Catheter for the treatment of drug refractory recurrent symptomatic paroxysmal atrial fibrillation, when used with compatible 3D electroanatomic mapping systems.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now